하나제약

293480KOSPI의약품 제조업

44.5 / 100

Reference Date: 2026-06-10

Financial Score16.5 / 40

News Sentiment15.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but Operating Profit is on a declining trend. Declined 7.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Hana Pharmaceutical specializes in the production and sale of specialty pharmaceuticals, with a strong presence in analgesics and anesthetics. The company offers a wide range of health insurance-listed drugs and operates manufacturing plants in Hwaseong, Gyeonggi, along with an R&D center in Pangyo.

Number of Employees

706people

Average Salary

53.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

17.81Industry Average 11.933.0Point

Higher than industry avg (caution)

PBR

0.51Industry Average 0.895.5Point

Lower than industry avg (good)

ROE

2.82Industry Average 4.012.5Point

Below industry avg

Debt Ratio

12.95Industry Average 12.432.0Point

Higher than industry avg (caution)

Trend 2023~20253.5 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲3.3% (2-year basis)

Operating Profit Growth Rate

0.5 / 3

Avg ▼2.2% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 6.1% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 1Neutral 2Negative 1Average Sentiment Score 60

Positive
하나제약 승계구도 변화?…장녀 조혜림 부사장 전면 부상
하나제약 내 조혜림 부사장의 경영 전면 부상으로 승계 구도 변화가 예상되며, 이는 기업의 미래 성장 동력 강화로 해석될 수 있다.
Neutral
하나제약, 6년 만에 삼진제약 지분 정리…배경은?
하나제약이 삼진제약 지분을 매각하는 결정은 장기적인 투자 전략 변화를 시사하지만, 직접적인 시장 영향은 제한적임을 나타냅니다.
Negative
하나제약, 이사회 재편 후 첫 스텝…삼진제약 지분 청산
하나제약의 삼진제약 지분 청산 결정은 최근 경영진 변화와 연관되어 기업 내부 불안정성을 반영하며 부정적 영향을 미칠 것으로 보인다.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 9,030Won52-week high 12,43052-week low 9,030

1-month return1.0Point

1m -7.57% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral최대주주등소유주식변동신고서2026-06-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-02
Neutral기업지배구조보고서공시2026-06-01
Neutral분기보고서 (2026.03)2026-05-15